NYSE: SCLStepan Co Stock
$88.30-1.04 (-1.16%)
Updated Dec 8, 2023
SCL Price
$88.30
Fair Value Price
N/A
Market Cap
$1.98B
52 Week Low
$63.60
52 Week High
$114.97
P/E
38.39x
P/B
1.64x
P/S
0.71x
PEG
0.39x
Dividend Yield
1.66%
Revenue
$2.42B
Earnings
$52.23M
Gross Margin
11.5%
Operating Margin
3.04%
Profit Margin
2.2%
Debt to Equity
0.94
Operating Cash Flow
$192M
Beta
0.88
Next Earnings
N/A
Ex-Dividend
Nov 29, 2023
Next Dividend
Dec 15, 2023
SCL Overview
Stepan Company manufacturers basic and intermediate chemicals, including surfactants, specialty products, phthalic anhydride, and polyurethane polyols. Surfactants are used in cleaning agents and consumer products like detergents, toothpaste, and cosmetics. Surfactants also have commercial and industrial applications ranging from emulsifiers for agricultural insecticides to agents used in oil recovery. The company also makes phthalic anhydride and other polymers for food and pharmaceutical uses. Stepan was founded in 1932 and is headquartered in Northbrook, IL.
Zen Score
–
Industry Average (39)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SCL scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SCL ($88.30) is trading below its intrinsic value of $88.55, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SCL is poor value based on its earnings relative to its share price (38.39x), compared to the US market average (31.32x)
P/E vs Market Valuation
SCL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more SCL due diligence checks available for Premium users.
Be the first to know about important SCL news, forecast changes, insider trades & much more!
SCL News
Valuation
SCL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
38.39x
Industry
59.4x
Market
31.32x
SCL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SCL is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
SCL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.64x
Industry
3.18x
SCL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SCL price to earnings growth (PEG)
For valuing profitable companies with growth potential
SCL is good value based... subscribe to Premium to read more.
PEG Value Valuation
SCL's financial health
Profit margin
Revenue
$562.2M
Net Income
$12.6M
Profit Margin
2.2%
SCL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SCL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.3B
Liabilities
$1.1B
Debt to equity
0.94
SCL's short-term assets ($849.44M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SCL's short-term assets ($849.44M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SCL's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SCL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$70.1M
Investing
-$53.7M
Financing
-$41.3M
SCL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SCL vs Specialty Chemical Stocks
Stepan Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.